Lenacapavir is already approved under the name Sunlenca as an HIV treatment for patients resistant to other medication ...
In a joint survey by Aidsfonds, GNP+ and the Robert Carr Fund 22% of organizations reported increased experiences of discrimination, including reports of discrimination within healthcare settings, ...
South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded ...
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...
Despite breakthroughs in HIV treatment and prevention worldwide, critical challenges such as stigma, unequal access and ...
If PEPFAR is not reauthorized for the next four years, and without other resources for the HIV response, there would be 6.3 ...
In the rural villages of South Africa, U.S. President Donald Trump’s sudden freeze on foreign aid impacts hundreds of ...
A generation has passed since the world saw the peak in AIDS-related deaths. Those deaths — agonizing, from diseases or ...
Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of V H 3 and V K 3 genes Structurally convergent antibodies ...
Anne Neilan, MD, MPH, an associate professor of Pediatrics and physician investigator in the Medical Practice Evaluation Center at Massachusetts General Hospital, is corresponding author of a new ...
Human immunodeficiency virus (HIV) is a virus that attacks the body's immune ... However, if left untreated, it can cause a weakened immune system or acquired immune deficiency syndrome (AIDS). Some ...